Pharma
Sun Pharmaceutical Industries Ltd
SUNPHARMA · NSE · INE044A01036Thursday, 10 Sept 202611:02 am
Market Cap—
P/E—
P/B—
EPS—
Div Yield—
ROE14.8%
ROCE17.6%
ROE14.8%
1Y Return+7.18%
Avg. Volume1.9M
Price Chart
52-Week Range
About
Sun Pharmaceutical Industries Ltd is a Pharma company listed on NSE.
Technicals
Free account
Register freeTechnicals
Create a free account to view momentum, moving averages, and delivery signals.
Quant
Premium
UpgradeQuant metrics
Upgrade to view volatility, drawdown, factor, and risk metrics.
Key Ratios
Market Cap—
Current Price₹1,854
52W High / Low₹2,046.9 / ₹1,548
Stock P/E—
Price to Book—
EPS (TTM)—
Dividend Yield—
ROE14.8%
1Y Return+7.18%
Day Change-0.78%
Profit & Loss
| Period | TTM | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹59,911 Cr | ₹58,462 Cr | ₹52,578 Cr | ||||||||||
| Expenses | ₹42,063 Cr | ₹41,961 Cr | ₹37,464 Cr | ||||||||||
| Operating Profit | ₹17,847 Cr | ₹16,501 Cr | ₹15,114 Cr | ||||||||||
| OPM % | 30.0% | 28.0% | 29.0% | ||||||||||
| Other Income | ₹1,537 Cr | ₹1,895 Cr | ₹1,444 Cr | ||||||||||
| Depreciation | ₹2,976 Cr | ₹2,938 Cr | ₹2,575 Cr | ||||||||||
| Interest | ₹364 Cr | ₹339 Cr | ₹231 Cr | ||||||||||
| Profit Before Tax | ₹16,045 Cr | ₹15,119 Cr | ₹13,752 Cr | ||||||||||
| Tax | ₹3,928 Cr | ₹3,610 Cr | ₹2,787 Cr | ||||||||||
| Net Profit | ₹12,117 Cr | ₹11,509 Cr | ₹10,965 Cr | ||||||||||
| EPS (₹) | 50.4 | 47.8 | 45.6 | ||||||||||
| Dividend Payout % | — | 33% | 35% |
Financial history locked
Register freeRegister free to see 10 more years.
Quarterly Results
| Quarter | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹15,300 Cr | ₹14,612 Cr | ₹15,521 Cr | ₹14,478 Cr | |||||||||
| Expenses | ₹10,882 Cr | ₹10,658 Cr | ₹10,572 Cr | ₹9,951 Cr | |||||||||
| Operating Profit | ₹4,418 Cr | ₹3,954 Cr | ₹4,948 Cr | ₹4,527 Cr | |||||||||
| OPM % | 29.0% | 27.0% | 32.0% | 31.0% | |||||||||
| Depreciation | ₹739 Cr | ₹775 Cr | ₹732 Cr | ₹730 Cr | |||||||||
| Interest | ₹100 Cr | ₹86 Cr | ₹78 Cr | ₹100 Cr | |||||||||
| Net Profit | ₹2,901 Cr | ₹2,710 Cr | ₹3,381 Cr | ₹3,125 Cr | |||||||||
| EPS (₹) | 12.1 | 11.3 | 14.0 | 13.0 |
Quarterly history locked
Register freeRegister free to see 9 more quarters.
Balance Sheet
| Period | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹240 Cr | ₹240 Cr | ₹240 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹83,330 Cr | ₹71,978 Cr | ₹63,427 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹4,627 Cr | ₹2,362 Cr | ₹3,274 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹20,210 Cr | ₹17,328 Cr | ₹18,387 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹1,08,407 Cr | ₹91,908 Cr | ₹85,328 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹32,822 Cr | ₹22,586 Cr | ₹23,248 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹24,723 Cr | ₹18,354 Cr | ₹15,026 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹47,811 Cr | ₹44,324 Cr | ₹41,700 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹1,08,407 Cr | ₹91,908 Cr | ₹85,328 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance sheet history locked
Register freeRegister free to see 10 more years.
Cash Flow
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| FY26 | ₹12,419 Cr | ₹-10,405 Cr | ₹-2,513 Cr | ₹-498 Cr |
| FY25 | ₹14,072 Cr | ₹-5,183 Cr | ₹-7,906 Cr | ₹983 Cr |
| FY24 | ₹12,135 Cr | ₹-763 Cr | ₹-6,710 Cr | ₹4,662 Cr |
| FY23 | ||||
| FY22 | ||||
| FY21 | ||||
| FY20 | ||||
| FY19 | ||||
| FY18 | ||||
| FY17 | ||||
| FY16 | ||||
| FY15 |
Cash flow history locked
Register freeRegister free to see 10 more years.
Peer Comparison
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| Dr Reddys Laboratories Ltd | — | — | +8.84% | -3.74% |
| Cipla Ltd | — | — | +11.77% | -5.50% |
| Apollo Hospitals Enterprise Ltd | — | — | +22.64% | +23.01% |
| Divis Laboratories Ltd | ₹2,50,065 Cr | 83.9 | +16.5% | +46.29% |
| Max Healthcare Institute Ltd | ₹1,00,553 Cr | 67.2 | +14.7% | +0.87% |
Mutual Fund Holdings
Free account
Register freeMutual fund holdings
Create a free account to see institutional ownership snapshots.
Bulk & Block Deals
Free account
Register freeBulk & block deals
Create a free account to view recent institutional deal activity.
Analyst Estimates
Free account
Register freeAnalyst estimates
Create a free account to view analyst estimate summaries.
Latest News
2026-09-09Incorporation Of A Subsidiary CompanyBSE Filing2026-08-31Trump Strikes Medicaid Drug Price Deals With Nine Pharma FirmsBloomberg2026-08-19Active Pharmaceutical Ingredients (API) Market Report 2026-2036 Just Released — Analyses Synthetic, Biotech, Traditional and Highly Potent APIsGlobeNewswire2026-07-30Earnings To Watch: Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) Q1 2027 -- GF Value Sees ...GuruFocus.com
Documents & Filings
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.